Robert Moccia

Chester Valley Pharmaceuticals, Inc. develops dermatological products. The company was founded by Robert J. Moccia in December 2004 and is headquartered in Malvern, PA.

Dermik Laboratories, Inc. manufactures health and skin care products. Its products and services include acne, actinic keratosis, nail fungus, dermatitis and eczema, and chemical peels treatment. The company was founded in 1947 and is located in Berwyn, PA.

Graceway Pharmaceuticals, LLC is a pharmaceutical company focused on bringing branded prescription products to the United States market through acquisition, in-licensing, and product development. It provides therapies in the form of products and drug delivery technologies, as well as creating opportunities for products and partners to gain access to the U.S. market through its sales force. The company was founded in 2006 and is headquartered in Bristol, TN.

iGuard, Inc. develops pharmaceutical treatments. The company is headquartered in Malvern, PA.

PreCision Dermatology, Inc. developed skincare therapies. It offered pharmaceutical products for skin barrier restoration, dermatoses, rosacea, acne, seborrheic dermatitis, and scaling associated with hyperkeratotic skin. The company was founded by Jeffrey M. Nugent in 2010 and was headquartered in Cumberland, RI.

Onset Dermatologics LLC develops and markets prescription product for skin disorders. The company was founded in 2005 and is headquartered in Cumberland, RI.

Medicis Pharmaceutical Corp. develops and markets pharmaceutical products for dermatological usages. It offers a broad range of products addressing various conditions or aesthetic improvements, including facial wrinkles, glabellar lines, acne, fungal infections, rosacea, hyperpigmentation, photoaging, psoriasis, seborrheic dermatitis and cosmesis. The company was founded on July 28, 1988 and is headquartered in Phoenix, AZ.

Part of Quintiles Transnational Corp., Bioglan Pharma, Inc. is a company that manufactures dermatology pharmaceuticals. The company is based in Malvern, PA. Bioglan Pharma was acquired by Quintiles Transnational Corp. from Bioglan Pharma Plc on March 22, 2002 for $26.70 million.